HARS1
HARS1 (histidyl-tRNA synthetase 1, also known as HisRS, HARS and USH3B) is a cytoplasmic class II aminoacyl-tRNA synthetase. It charges tRNA with histidine, a step that is essential for incorporating histidine into proteins, and it has also been linked to axon guidance. Browse Assay Genie's current range of HARS1 research reagents below, or read on for the biology behind the target.
HARS1 catalyses the ATP-dependent ligation of histidine to the 3'-end of its cognate tRNA. The reaction proceeds through an aminoacyl-adenylate intermediate, His-AMP. The product, histidyl-tRNA, is required for the incorporation of histidine into proteins, so the enzyme sits at a core step of translation. UniProt also annotates a role for the protein in axon guidance.
The HARS1 protein is a cytoplasmic enzyme and belongs to the class II family of aminoacyl-tRNA synthetases, the group of enzymes that charge tRNAs with their cognate amino acids. In HGNC it is placed in the class II aminoacyl tRNA synthetase gene group. The HARS1 gene lies in a head-to-head orientation with HARSL on chromosome five, and the two homologous genes share a bidirectional promoter. Several transcript variants encoding different isoforms have been reported.
The enzyme is known by several names, including histidyl-tRNA synthetase, HisRS and HARS. The symbol USH3B, and the previous name Usher syndrome 3B, also appear in the nomenclature for this gene. HARS1 is a frequent target of autoantibodies in the autoimmune disease polymyositis/dermatomyositis, which makes it a recurring subject in autoimmunity research. The mouse ortholog is designated Hars1.
HARS1 synthesises histidyl-tRNA through a His-AMP intermediate, making it a model for studying how histidine is supplied for protein synthesis.
The gene product is a frequent autoantibody target in polymyositis/dermatomyositis, so HARS1 is relevant to studies of autoimmune myopathy.
UniProt annotates a role for HARS1 in axon guidance, linking a core translation enzyme to neuronal development.
As a class II synthetase, HARS1 supports comparative work on how tRNA synthetases recognise their cognate amino acids and tRNAs.
HARS1 catalyses the ATP-dependent attachment of histidine to the 3'-end of its cognate tRNA via a His-AMP intermediate. This produces histidyl-tRNA, needed to incorporate histidine into proteins. UniProt also notes a role in axon guidance.
HARS1 is also called HisRS, HARS and USH3B. Earlier names include histidyl-tRNA synthetase and Usher syndrome 3B. UniProt lists the protein as histidine--tRNA ligase, cytoplasmic. NCBI notes that several transcript variants encode different isoforms.
HARS1 is a frequent target of autoantibodies in polymyositis/dermatomyositis. A mouse ortholog, Hars1, exists. Researchers should check the datasheet of any product for its validated reactivity.
Other aminoacyl-tRNA synthetases and related translation-pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P12081; product specifications from Assay Genie datasheets.